Real world experience of response to pirfenidone in patients with idiopathic pulmonary fibrosis: a two centre retrospective study

INTRODUCTION: Pirfenidone has been shown to reduce the decline in forced vital capacity (FVC) compared to placebo in patients with idiopathic pulmonary fibrosis (IPF). Previous studies have suggested that patients with a more rapid decline in FVC during the period before starting pirfenidone experie...

Descripción completa

Detalles Bibliográficos
Autores principales: Eaden, James A., Barber, Christopher M., Renshaw, Stephen A., Chaudhuri, Nazia, Bianchi, Stephen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2020
Materias:
Original Article: Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569563/
https://www.ncbi.nlm.nih.gov/pubmed/33093786
http://dx.doi.org/10.36141/svdld.v37i2.8587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569563/
https://www.ncbi.nlm.nih.gov/pubmed/33093786
http://dx.doi.org/10.36141/svdld.v37i2.8587

Ejemplares similares